Home > Request Information
Title:
Neurizon Receives Ethics Approval for Phase 1 NUZ-001 Oral Liquid Formulation Study
* Company:
* Country:
* Name:
Job Title:
* Tel:
Fax:
* E-mail:
Message:
Verification Code:
refresh